By Jennifer N. Conrad, Managing Editor
For millions of patients seeking cutting-edge regenerative therapies, the promise is vast, but the data is scarce. What if the treatment you need exists, but there’s no evidence to prove it works? DataBiologics is changing that.
A Patient’s Journey: The Need for Data
Meet a patient struggling with chronic knee pain. After years of unsuccessful treatments, they considered regenerative therapy—but without reliable data, they had no way of knowing if it would work for them. His doctor, like many others, lacked the real-world evidence necessary to confidently recommend the treatment. This is the gap DataBiologics is closing.
A Frustrated Physician’s Vision Turned National Movement
It all began with a simple but urgent question: How do we prove that regenerative treatments truly work? The early days of DataBiologics were driven by a group of physicians who wanted more than anecdotal evidence—they wanted real data to back up their innovative treatments.
“The early days of DataBiologics were all about physicians trying new treatments and wanting to actually study what was happening—for their patients and their practices,” says Leah Braddell, CEO of the Mesa, Arizona-based company. What started as one physician’s frustration has grown into a national movement transforming healthcare, all inspired by the vision of Gerard Malanga, MD.
Braddell was initially brought in as an advisor. With a background in engineering and medical technology, she was asked to help shape the platform into something more scalable. But what began as a consulting role quickly turned into a passion. She recognized the immense need for a data-driven approach to regenerative medicine, and within months, she became a driving force behind DataBiologics. “I saw the potential to make a real impact—not just in medicine but in how healthcare decisions are made every day,” Braddell recalls.
A Vision Rooted in Data
Dr. Malanga, a pioneer in regenerative medicine and former president of the Interventional Orthobiologics Foundation, recognized a critical gap years ago. He saw the immense potential of regenerative treatments but also the urgent need for data to validate their effectiveness and personalize patient care.
“If we’re going to advance the industry, we need data that informs decision-making,” Braddell explains, echoing Dr. Malanga’s belief that a national registry was essential for tracking patient outcomes. Although Dr. Malanga passed away in 2022, his vision remains the driving force behind DataBiologics. His dedication to bridging the gap between innovative treatments and real-world evidence continues to inspire the company’s mission.
Today, DataBiologics, with Dr. Malanga’s son, Luke, on the team alongside Braddell, is turning that vision into reality. The company has built a platform that enables healthcare providers to collect and analyze meaningful treatment data, accelerating the adoption of promising new techniques while personalizing patient care.
“We’re not just building software,” Braddell emphasizes. “We’re building a future where regenerative and orthopedic treatments are grounded in real-world evidence, ensuring patients receive the best possible care.”
Arizona: A Hub for Innovation
DataBiologics’ roots are deeply embedded in Arizona’s thriving tech and medical research ecosystem. Braddell, an Arizona native and graduate of Arizona State University’s prestigious engineering program, credits the state’s entrepreneurial support and innovation-driven culture as key factors in the company’s success.
“Arizona is the perfect place for innovation. We have top engineering schools, strong entrepreneurial support, and a culture that embraces new technology,” she explains. “The state has really positioned itself as a leader in emerging medical research, and that’s a big reason why we’ve been able to scale so quickly.”
The company has also benefited from the Mesa LaunchPoint incubator, which has provided mentorship, office space, and essential resources. “Mesa LaunchPoint has played a key role in our development, offering a collaborative environment for innovation,” Braddell shares. The incubator has connected DataBiologics with investors, government officials, and other healthcare innovators, fostering critical relationships that support their continued expansion.
How The Platform Works
DataBiologics has developed a seamless, physician-friendly platform that integrates with existing healthcare workflows, including electronic health records (EHRs).
“It has to be simple for doctors,” Braddell explains. “They’re busy caring for people, not wrestling with complicated software.”
The platform enables physicians to easily input patient data, treatment plans, and track long-term outcomes. It aggregates comprehensive datasets—demographics, treatment protocols, medical images, and patient-reported outcomes—which are then analyzed by AI-driven algorithms.
“Imagine a doctor treating a patient with a knee injury. With DataBiologics, they can compare thousands of similar cases in seconds, predicting the most effective treatment plan with real-world evidence,” Braddell notes. “Our AI can analyze thousands of data points in minutes—something that would take a human clinician hours or even days. It helps doctors make better decisions, faster, leading to better patient outcomes.”
Beyond efficiency, DataBiologics’ AI uncovers hidden patterns in regenerative medicine. By analyzing medical images, it can detect subtle tissue regeneration changes that might be invisible to the human eye, allowing doctors to intervene earlier and optimize treatments.
Security and privacy are also top priorities. “We know this information is sensitive,” Braddell assures. “We have strong safeguards in place to protect it and comply with all regulations.”
Real-World Impact
The impact of DataBiologics’ work is already evident. The company has partnered with leading healthcare institutions such as Emory Healthcare, OhioHealth, and the Michigan Center for Regenerative Medicine, facilitating over 25,000 patient cases for research and analysis.
These partnerships are not just about expansion but about uniting healthcare providers committed to advancing regenerative medicine. Dr. Thomas Nabity of the Michigan Center explains, “DataBiologics helps us make smarter treatment decisions, give our patients better care, and push the field forward.”
Looking Ahead
DataBiologics has ambitious plans for the future. The company is expanding its team, refining its AI technology, and broadening its reach to more healthcare providers nationwide. Committed to hiring locally, they aim to contribute to Arizona’s growing biotech sector while making a national impact.
“We’re just getting started,” Braddell affirms. “We want to equip healthcare providers with the best tools to make informed decisions for their patients. We’re not just collecting data; we’re shaping a future where healthcare is more personal, effective, and accessible—all while keeping Arizona at the heart of our mission.”
Are you ready to be part of the data revolution in regenerative medicine? Learn more and join the movement at www.databiologics.com.
